DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20175457

Fresh frozen plasma utilization pattern in tertiary care hospital of North Western India

Nippun Prinja, Sarita Sharma, Rachna Narain

Abstract


Background: Fresh Frozen Plasma (FFP) is mainly used in treatment of coagulation derangements; trauma emergencies. It is the most inappropriately used blood component. Since the guidelines for FFP use in a clinical setting are not well defined, this study aims at defining the appropriateness of use of FFP in the light of its risks and adverse effect. Audit of institute FFP usage with specific aim of assessing appropriate use, based on clinical indications and laboratory parameters in requisition form.

Methods: Retrospective analysis of 10,753 FFP supplied in 3072 patients from June 2016 to December 2016 in SMS Hospital, Jaipur, Rajasthan, India was done in Department of Immunohaematology and Transfusion Medicine, SMS Hospital, Jaipur, Rajasthan, India. Detailed analysis of clinical indication, INR value, specialty, age, gender of patient was done.

Results: 10,753 FFP was supplied to 3072 Patients. 6990 FFP was supplied to 1995 males. 3763 FFP was supplied to 1077 females. Clinical use of FFP for medical and surgical conditions was highest seen in Blood Cancers (13%) and Cardiosurgery (22.3%). 15.2% was available from Emergency Department. 1.9% of FFP was returned back. Patients with Deranged Coagulation Profile (DCP) require maximum transfusion (49.3), Bleeding patients (37.6%), DIC (3.3%). FFP used for plasmapheresis (2.6%). No information available about diagnosis (7.2%) was available from Emergency Department.

Conclusions: FFP is most inappropriately used blood component (39.57%) and should be used judiciously. Regular audit of blood components serves as tool for accomplishment of quality tools and to understand clinical transfusion practices.


Keywords


Audit, Inappropriately, Plasma

Full Text:

PDF

References


Stanworth SJ. The evidence-based use of FFP and cryoprecipitate for abnormalities of coagulation tests and clinical coagulopathy. Hematol Am Soc Hematol Educ Program. 2007;2007(1):179-86.

O’Shaughnessy DF, Atterbury C, Bolton Maggs P, Murphy M, Thomas D, Yates S et al. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol. 2004;126:11-28.

Makroo RN. Transfusion medicine compendium. 1st ed. Career Publications;1999:127-53.

British Committee for Standards in Hematology working party of the Blood Transfusion Task Force. Guidelines for the use of fresh frozen plasma. Transfusion Medicine. 1992;2:57-63.

National Health and Medical Research Council (NHMRC) ASoBTA. Clinical Practice Guidelines on the Use of Blood Components (red blood cells, platelets, fresh frozen plasma and cryoprecipitate) 2002. Available at: http://www.nhmrc.health.gov.au.

O’Shaughnessy DF, Atterbury C, Bolton MP. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol. 2004;126:11-28.

Task Force on Blood Component Therapy. Practice Guidelines for blood component therapy: a report by the American Society of Anesthesiologists. Anesthesiology. 1996;83:732-47.

Bowden R, Sayers M. The risk of transmitting cytomegalovirus infection by fresh frozen plasma. Transfusion. 1990;30:762-3.

Kleinman S, Caulfield T, Chan P. Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion. 2004;44:1774-89

Chng WJ, Tan MK, Kuperan P. An audit of fresh frozen plasma usage in an acute general hospital in Singapore. Singapore Med J. 2003;44:574-8.

Kakkar N, Kaur R, Dhanoa T. A prospective audit of transfusion requests in a tertiary hospital. Indian J Haematol Blood Transf. 2003;21:159-60.

Vishwanathan C, Jain R, Kamath M. Blood utilization review in a tertiary care hospital. Indian J Haematol Blood Transf. 1999;17:26-31.

Basu S, Marwaha N. Fresh frozen plasma: Indications and patterns of usage. Indian J Haematol Blood Transf. 2001;19:51-2.

Chatterjee M, Bharucha ZS. Retrospective audit of transfusion practice in surgical oncology. Indian J Hematol Blood Transf. 1998;16:107-12.

Eagleton H, Benjamin S, Murphy MF. Audits of appropriate use of FFP. Blood Matters. 2000;4:5-8.

Hui CH, Williams I, Davis K. Clinical audit of the use of fresh-frozen plasma and platelets in a tertiary teaching hospital and the impact of a new transfusion request form. Intern Med J. 2005;35:283-8.

Luk C, Eckert KM, Barr RM, Chin-Yee IH. Prospective audit of the use of fresh-frozen plasma based on Canadian Medical Association transfusion guidelines. CMAJ. 2002;166:1539-40.